Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-02-18

Clinical Trial Update: A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular Dystrophy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating chronotherapy of corticosteroids in Duchenne muscular dystrophy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corticosteroids (chronotherapy)

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Duchenne Muscular Dystrophy (DMD) | Phase 2 | Status: WITHDRAWN